INTERNATIONAL PATENT: TESSERACT MEDICINES US, LLC FILES APPLICATION FOR "COVALENT-INDUCED DRUG CONJUGATES TARGETING KRAS AND COMPRISING A TOPOISOMERASE PAYLOAD"

GENEVA, Feb. 18 -- TESSERACT MEDICINES US, LLC (365 Boston Post RoadSudbury, Massachusetts 01776) filed a patent application (PCT/US2025/041101) for "COVALENT-INDUCED DRUG CONJUGATES TARGETING KRAS AND COMPRISING A TOPOISOMERASE PAYLOAD" on Aug 07, 2025. With publication no. WO/2026/035945, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CASTRO, Alfredo C. (c/o Tesseract Medicines US, LLC365 Boston Post RoadSudbury, Massachusetts 01776), CALANDRA, Nicholas (c/o Tesseract Medicines US, LLC365 Boston Post RoadSudbury, Massa...